CF PharmTech, Inc. — Investor Relations & Filings
Filings indexed
80
across all filing types
Latest filing
2026-05-05
Regulatory Filings
Country
HK
Hong Kong
Listing
HKEX
2652
CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | |
| 2025 Environmental, Social and Governance Report | 2026-04-30 | English | |
| 2025 Annual Report | 2026-04-30 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | |
| NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41372493 | NEXT DAY DISCLOSURE RETURN | 2026-05-05 | English | ||
| 40869494 | NEXT DAY DISCLOSURE RETURN | 2026-05-04 | English | ||
| 39090420 | 2025 Environmental, Social and Governance Report | 2026-04-30 | English | ||
| 39083797 | 2025 Annual Report | 2026-04-30 | English | ||
| 39062062 | NEXT DAY DISCLOSURE RETURN | 2026-04-30 | English | ||
| 37991777 | NEXT DAY DISCLOSURE RETURN | 2026-04-28 | English | ||
| 37399646 | NEXT DAY DISCLOSURE RETURN | 2026-04-27 | English | ||
| 36145217 | NEXT DAY DISCLOSURE RETURN | 2026-04-24 | English | ||
| 35737075 | NEXT DAY DISCLOSURE RETURN | 2026-04-23 | English | ||
| 35229316 | NEXT DAY DISCLOSURE RETURN | 2026-04-22 | English | ||
| 34743258 | NEXT DAY DISCLOSURE RETURN | 2026-04-21 | English | ||
| 34691867 | NEXT DAY DISCLOSURE RETURN | 2026-04-20 | English | ||
| 33902250 | NEXT DAY DISCLOSURE RETURN | 2026-04-09 | English | ||
| 33797095 | Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 | 2026-04-08 | English | ||
| 33154578 | NEXT DAY DISCLOSURE RETURN | 2026-04-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode Corporation
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
CF PharmTech, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/50735/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=50735 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=50735 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=50735 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 50735}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CF PharmTech, Inc. (id: 50735)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.